Two antimycin A analogues from marine-derived actinomycete Streptomyces lusitanus

Mar Drugs. 2012 Mar;10(3):668-676. doi: 10.3390/md10030668. Epub 2012 Mar 22.

Abstract

Two new antimycin A analogues, antimycin B1 and B2 (1-2), were isolated from a spent broth of a marine-derived bacterium, Streptomyces lusitanus. The structures of 1 and 2 were established on the basis of spectroscopic analyses and chemical methods. The isolated compounds were tested for their anti-bacterial potency. Compound 1 was found to be inactive against the bacteria Bacillus subtilis, Staphyloccocus aureus, and Loktanella hongkongensis. Compound 2 showed antibacterial activities against S. aureus and L. hongkongensis with MIC values of 32.0 and 8.0 μg/mL, respectively.

Keywords: Streptomyces lusitanus; antibacterial; antimycin B; marine-derived actinomycete.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / biosynthesis*
  • Anti-Bacterial Agents / pharmacology*
  • Antimycin A / analogs & derivatives*
  • Antimycin A / biosynthesis
  • Antimycin A / pharmacology*
  • Aquatic Organisms
  • Bacteria / drug effects
  • Chromatography, High Pressure Liquid
  • Culture Media
  • Indicators and Reagents
  • Lactones / chemistry
  • Magnetic Resonance Spectroscopy
  • Microbial Sensitivity Tests
  • Molecular Conformation
  • Spectrophotometry, Ultraviolet
  • Streptomyces / genetics
  • Streptomyces / growth & development
  • Streptomyces / metabolism*
  • Threonine / chemistry

Substances

  • Anti-Bacterial Agents
  • Culture Media
  • Indicators and Reagents
  • Lactones
  • antimycin B1
  • antimycin B2
  • Threonine
  • Antimycin A